Literature DB >> 28791872

Short Communication: Mycobacterium avium Complex Infection and Immune Reconstitution Inflammatory Syndrome Remain a Challenge in the Era of Effective Antiretroviral Therapy.

Olivia C Smibert1, Jason A Trubiano1, Gail B Cross1, Jennifer F Hoy1.   

Abstract

A 10-year review of disseminated Mycobacterium avium complex (MAC) infection and MAC-immune reconstitution inflammatory syndrome in HIV-positive patients (2004-2014) at a state-wide tertiary referral HIV service demonstrates that despite advances in antiretroviral therapy, MAC infection remains a therapeutic challenge, particularly intra-abdominal disease.

Entities:  

Keywords:  HIV; IRIS; MAC; Mycobacterium avium complex; antiretroviral therapy; immune reconstitution

Mesh:

Substances:

Year:  2017        PMID: 28791872     DOI: 10.1089/AID.2017.0030

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  3 in total

1.  Nontuberculous mycobacterial infections in a Brazilian pediatric population: a seven-year survey.

Authors:  Renan M Mauch; Andrea A S Mansinho; Priscilla M O Rocha; Tânia R Zaccariotto; Carlos E Levy; Marcos T Nolasco da Silva
Journal:  Pathog Glob Health       Date:  2020-02-08       Impact factor: 2.894

2.  Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against Mycobacterium avium infection but is ineffective as an adjunct to antibiotic treatment in chronic disease.

Authors:  Ju Mi Lee; Jiyun Park; Steven G Reed; Rhea N Coler; Jung Joo Hong; Lee-Han Kim; Wonsik Lee; Kee Woong Kwon; Sung Jae Shin
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

3.  Large abscess formed in the abdominal wall by Mycobacterium avium complex: A case of unmasking immune reconstitution inflammatory syndrome.

Authors:  Narika Yanagisawa; Seisho Takeuchi; Miho Nakamura; Yukitaka Yoshida; Katsuji Teruya; Kiyonori Takada
Journal:  IDCases       Date:  2019-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.